Successful treatment of hemolytic uremic syndrome after liver-kidney transplantation

Journal of Nephrology

Volumn 16, Issue 4, 2003, Pages 586-590

  Gatti, Stefano ^a   Arru, Marcella ^a   Reggiani, Paolo ^a   Como, Giovanna ^a   Rossi, Francesca ^a   Fassati, Luigi R ^a   Ponticelli, Claudio ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Combined liver and kidney transplantation; Hemolytic uremic syndrome; Solid organ transplantation

Indexed keywords

AMPHOTERICIN B; CORTICOSTEROID DERIVATIVE; CYCLOSPORIN A; DALFOPRISTIN PLUS QUINUPRISTIN; FRESH FROZEN PLASMA; HEPARIN; IMIPENEM; IMMUNOGLOBULIN; METHYLPREDNISOLONE; PREDNISONE; TACROLIMUS; VANCOMYCIN;

ABDOMINAL PAIN; ADULT; ANURIA; ARTICLE; BACTEREMIA; BIOCHEMISTRY; CASE REPORT; CLINICAL FEATURE; CYTOMEGALOVIRUS INFECTION; DELIRIUM; DISEASE SEVERITY; DISORIENTATION; DROWSINESS; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG DOSE REGIMEN; DRUG TOXICITY; DRUG WITHDRAWAL; DYSPNEA; FEMALE; GRAFT REJECTION; HEMOLYTIC ANEMIA; HEMOLYTIC UREMIC SYNDROME; HEPATOJEJUNOSTOMY; HEPATOMEGALY; HOSPITAL DISCHARGE; HUMAN; HUMAN TISSUE; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; JEJUNUM DISEASE; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY POLYCYSTIC DISEASE; KIDNEY TRANSPLANTATION; LABORATORY TEST; LAPAROTOMY; LIVER BIOPSY; LIVER POLYCYSTIC DISEASE; LIVER TRANSPLANTATION; LOW DRUG DOSE; LUNG ASPERGILLOSIS; LUNG INFECTION; MENTAL DISEASE; NERVE INJURY; NEUROLOGIC DISEASE; PLASMA TRANSFUSION; PLASMAPHERESIS; POSTOPERATIVE PERIOD; RECIPIENT; STREPTOCOCCUS INFECTION; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TREATMENT FAILURE; TREATMENT OUTCOME;

COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HEMOLYTIC-UREMIC SYNDROME; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; KIDNEY FUNCTION TESTS; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MIDDLE AGED; PLASMAPHERESIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 1642476669     PISSN: 11218428     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Singh N, Gayowski T, Marino I. Hemolytic uremic syndrome in solid-organ transplantation recipients. Transpl Int 1996; 9: 68-75.
2. Sommer BG, Henry ML, Ferguson RM. Cyclosporin-associated obliterative renal arteriopathy. Transplant Proc 1986; 18: 151-7.
3. Shulman H, Striker G, Deeg HG, Kennedy M, Starb R, Thomas ED. Nephrotoxicity of cyclosporin A after allogenic bone marrow transplantation. New Engl J Med 1981; 305: 1392-5.
4. Berden JH, Netten P, Van Liessum PA. Hemolytic-uremic syndrome during cyclosporine immunosuppression in renal allograft recipients. Clin Transplant 1987; 1: 246-50.
5. Schmidt RJ, Venkat KK, Dumler F. Hemolytic-uremic syndrome in a renal transplant recipient on FK506 immunosuppression. Transplant Proc 1991; 23: 3156-7.
6. Van Buren D, Van Buren CT, Flechner SM, Maddox AM, Verani R, Kahan BD. De novo hemolytic uremic syndrome in renal transplant recipients immunosuppressed with cyclosporine. Surgery 1985; 98: 54-62.
7. Young BA, Marsh CL, Alpers CE, Davis CL. Cyclosporine-associated thrombotic microangiopathy/hemolytic uremic syndrome following kidney and kidney-pancreas transplantation. Am J Kidney Dis 1996; 28: 561-71.
8. Bonser RS, Adu D, Franklin I, McMaster P. Cyclosporin-induced haemolytic uraemic syndrome in liver allograft recipient. Lancet 1984; 2: 1337.
9. Galli FC, Damon LE, Tamlonovich SJ, Keith F, Chatterjee K, De Marco T. Cyclosporine-induced hemolytic uremic syndrome in a heart transplant recipient. J Heart Lung Transplant 1993; 12: 440-4.
10. Butkus DE, Herrerra GA, Raju SS. Successful renal transplantation after cyclosporine-associated hemolytic uremic syndrome following bilateral lung transplantation. Transplantation 1992; 54: 159-62.
11. Ruggenenti P. Post-transplant hemolytic-uremic syndrome. Kidney Int 2002; 62: 1093-104.
12. Hochstetler LA, Flanigan MJ, Lager DJ. Transplant-associated thrombotic microangiopathy: The role of IgG administration as initial therapy. Am J Kidney Dis 1994; 23: 444-50.
13. Rerolle JP, Akposso K, Lerolle N, Mougenot B, Ponelle T, Rondeau E, Sraer JD. Tacrolimus-induced hemolytic uremic syndrome and end-stage renal failure after liver transplantation. Clin Transplant 2000; 14: 262-5.
14. Dussol B, Brunet P, Vacher-Coponat H, Saingra Y, Casanova P, Berland Y. Hemolytic uremic syndrome in renal transplant recipient during OKT3 therapy. Nephrol Dial Transplant 1994; 9: 1191-3.
15. Neild GH, Reuben R, Hartley RB, Cameron JS. Glomerular thrombi in renal allografts associated with cyclosporin treatment. J Clin Pathol 1985; 38: 253-8.
16. Dzik WH, Georgi BA, Khettry U, Jenkins RL. Cyclosporine associated thrombotic thrombocytopenic purpura following liver transplantation - Successful treatment with plasma exchange. Transplantation 1987; 44: 570-2.
17. McCauley J, Bronsther O, Fung J, Todo S, Starzl TE. Treatment of cyclosporin-induced hemolytic uraemic syndrome with FK506. Lancet 1989; 2: 1516.
18. Richardson D, Jones CH, Newstead CG, Will EJ, Lodge JP. The successful conversion to tracolimus of a renal transplant recipient with cyclosporin-induced hemolytic uremic syndrome. Nephrol Dial Transplant 1996; 11: 2498-500.
19. Rock GA, Shumak KH, Buskard NA, Blanchette VS, Kelton JG, Nair RC, Spasoff RA. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. N Engl J Med 1991; 325: 393-7.
20. Venkat KK, Tkach D, Kupin W, Mozes M, Oh HK, Raman BK, Visscher D, Lee MW. Reversal cyclosporine-associated hemolytic-uremic syndrome by plasma exchange with fresh-frozen plasma replacement in renal transplant recipients. Transplant Proc 1991; 23: 1256-7.
21. Candinas D, Keusch G, Schlumpf R, Burger HR, Weder W, Largiader F. Prognostic factors of hemolytic uremic syndrome in renal allograft. Transplant Proc 1993; 25: 1041-2.
22. Chandler WL, Jellacic S, Boster DR, Ciol MA, Williams GD, Watkins SL, Igarashi T, Tarr PI. Prothrombotic coagulation abnormalities preceding the hemolytic uremic syndrome. N Engl J Med 2000; 346: 23-32.
23. Wong CS, Jelacic S, Habeeb RL, Watkins SL, Tarr PI. The risk of the hemolytic uremic syndrome after antibiotic treatment of Escherichia coli 0157:H7 infections. N Engl J Med 2000; 342: 1930-6.
24. Furlan M, Robles R, Galbusera M, Remuzzi G, Kyrle PA, Brenner B, Krause M, Sharrer I, Aumann V, Mittler U, Solenthaler M, Lammle B. Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med 1998; 339: 1578-84.
25. Tsai HM, Lian E. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med 1998; 339: 1585-94.
26. Elliot MA, Nichols WL. Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. Mayo Clin Proc 2001; 76: 1154-62.